Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytoflavin in Diabetic Polyneuropathy
NCT04649203Phase 3Completed
- Sponsor
- POLYSAN
- Start
- Nov 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cytoflavin in diabetic polyneuropathy (DPN), sponsored by POLYSAN. Started Nov 2020; status: completed.
02
Drugs
Cytoflavin
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT04649203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04649203.